Immunological considerations for laboratory staff and COVID-19 biosafety

• Váldodahkkit: Ambroise Kouame Kintossou (Dahkki), Stephanie Villar (Dahkki), Zisis Kozlakidis (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Elsevier, 2023-04-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

The vulnerability of healthcare and laboratory to potential infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has thus far been analyzed through the lens of the acute phase of the pandemic, including remote-based work, as well as emergency settings that are differen...